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Background & Objective: In this study, thyroid dysfunction in women with 
gestational diabetes mellitus was examined and compared to that in healthy pregnant 
women referred to Kowsar Hospital in Qazvin in 2017 and 2018. 
Materials & Methods: In this case-control study, 100 women with gestational diabetes 
mellitus and 100 non diabetic healthy pregnant women who referred to Kowsar Hospital in 
Qazvin from 2017 to 2018 were selected using the convenience sampling method, and their 
serum thyroxine, anti-TPO, and TSH levels were determined and compared. Moreover, 
Apgar scores and anthropometric variables were compared between the two groups. 
Results: In the present study, there were statistically significant differences between the 
groups in terms of the TSH level (P=0.012), assessed by the independent t-test, the 
thyroxine (P=0.0001) and anti-TPO (P=0.008) levels, both examined by the Mann-
Whitney test, which associated with high levels of TSH and anti-TPO and low levels of 
thyroxine in the diabetic group. No differences were found regarding the Apgar scores and 
anthropometric variables between the groups (P>0.05). 
Conclusion:  Overall, according to the obtained results, it can be inferred that thyroid 
dysfunction, realized as hypothyroid with high anti-TPO levels, was more prevalent 
in women with gestational diabetes mellitus compared to healthy pregnant women. 
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Introduction
Gestational diabetes mellitus (GDM) and thyroid 
dysfunction in pregnancy are among the most prevalent 
diseases that influence pregnancy outcomes (1). 
Diabetes is one of the most common metabolic diseases 
associated with elevated blood glucose and metabolic 
alternations in lipids, sugars, and proteins, which has a 
prevalence of 3.5-5% during pregnancy (2). Its known 
complications during pregnancy include preeclampsia, 
preterm labor, miscarriage, congenital anomalies, 
shoulder dystocia, and stillbirth for the fetus. 
Accordingly, it is a strong risk factor for adverse 
pregnancy outcomes (3) . The effects of diabetes will 
remain even after childbirth, and approximately 40% 
of women with GDM will develop overt diabetes 
within the next 20 years (4) . Harmful effects of thyroid 
dysfunction during pregnancy have been proven to 
affect the course of pregnancy and fetal development 
(5). The fetus needs thyroxine for normal growth, 
especially for brain development, and since the 
production and secretion of fetal thyroid hormones do 
not occur until the 20th week of pregnancy, fetal 
growth in the first trimester is completely dependent on 
the thyroxine transferred from the mother (6). There is 
a close correlation between maternal thyroid function 
and pregnancy outcomes; it has been observed that the 
presence of thyroid autoantibodies in the mother’s 
blood associates with an increase in fetal loss in early 
pregnancy (7) . Both untreated thyrotoxicosis and 
hypothyroidism relate to adverse pregnancy outcomes 
(8). Even in several studies, the presence of subclinical 
hypothyroidism associated with increased pregnancy 
complications, including placental abruption 
(increased three times), preterm labor (increased 
twice), and infants with low birth weight (increased 
twice). Furthermore, various conducted studies 
indicated that increased thyroid peroxidase antibodies 
